Sirolimus is a potent immunosuppressant drug belonging to the macrolide class, primarily utilized to prevent organ transplant rejection and to treat specific cancers by inhibiting the mTOR signaling pathway.… Read more
Sirolimus is a potent immunosuppressant drug belonging to the macrolide class, primarily utilized to prevent organ transplant rejection and to treat specific cancers by inhibiting the mTOR signaling pathway. This category provides essential reference standards for the Sirolimus active pharmaceutical ingredient, alongside its related substances, including pharmacopeial and non-pharmacopeial impurities such as Everolimus Impurity A. Additionally, stable isotope labelled compounds like Sirolimus-D3 and Sirolimus-13C-d3 are included to support precision in analytical testing. Laboratories rely on these high-quality materials for impurity profiling, method validation, and rigorous quality control protocols during pharmaceutical development and regulatory compliance testing. By utilizing these characterized standards, researchers can ensure accurate identification and quantification of impurities and metabolites, maintaining the highest levels of accuracy in their experimental and diagnostic workflows.